Blog
RSS FeedPosted by Michael Wonder on 13 Jun 2018
Mylan CEO promises Neulasta biosimilar will offer "significant savings" for patients
12 June 2018 - Nearly two years after taking tremendous heat for the rising cost of EpiPens, pharmaceutical giant Mylan ...
Posted by Michael Wonder on 09 Jun 2018
Easier drug approval isn’t cutting drug prices
8 June 2018 - Dr. Scott Gottlieb, the commissioner of the FDA, recently vowed to bring “new science” to market ...
Posted by Michael Wonder on 22 May 2018
Make drugs cheaper by encouraging generics
22 May 2018 - The FDA is pushing in that direction. Congress could do much more. ...
Posted by Michael Wonder on 20 May 2018
Requiring prices in drug ads: would it do any good? Is it even legal?
19 May 2018 - A commercial for Neulasta, a drug that reduces the risk of infections after chemotherapy. If President Trump ...
Posted by Michael Wonder on 18 May 2018
FDA looking at ways to include price info in drug ads, Gottlieb says, as questions loom
18 May 2018 - The commissioner of the FDA, Scott Gottlieb, said a proposal to have pharmaceutical companies include drug ...
Posted by Michael Wonder on 18 May 2018
How a migraine drug is easing the headache of high prices
19 May 2018 - Amgen and Novartis got it right this time by not charging as much as they could. Their ...
Posted by Michael Wonder on 16 May 2018
FDA explores requiring drug price disclosures in commercials
15 May 2018 - Drug companies on Tuesday claimed the Trump administration may not have the legal authority to make ...
Posted by Michael Wonder on 12 May 2018
Statement from FDA Commissioner on the Trump Administration’s plan to lower drug prices
11 May 2018 - Today is an important day in the Administration’s collaborative effort to address the rising cost of ...
Posted by Michael Wonder on 05 May 2018
Novartis matches Gilead on price in new CAR-T use
3 May 2018 - Novartis’ CAR-T therapy Kymriah will be available in the US to adults with relapsed large B-cell ...
Posted by Michael Wonder on 21 Apr 2018
FDA commissioner to drug middlemen: you're part of the problem
19 April 2018 - The FDA has approved nine biosimilars, generic versions of biologic medicines, but only three are available in ...
Posted by Michael Wonder on 19 Apr 2018
Price tag for newly approved Crysvita is "responsible," says PBM Express Scripts
18 April 2018 - Taking the rebates that it expects to negotiate into consideration, Ultragenyx said that burosumab will cost approximately ...
Posted by Michael Wonder on 14 Mar 2018
FDA chief becomes point man on drug prices
14 March 2018 - Scott Gottlieb, head of the FDA, has emerged as a key figure in the Trump administration’s ...
Posted by Michael Wonder on 07 Mar 2018
‘Rigged’ system blocks use of lower cost drugs, FDA Chief says
7 March 2018 - FDA has approved nine biosimilars, only three for sale in U.S. ...
Posted by Michael Wonder on 25 Feb 2018
Patients eagerly awaited a generic drug. Then they saw the price.
23 February 2018 - When Teva Pharmaceuticals announced recently that it would begin selling a copycat version of Syprine — ...
Posted by Michael Wonder on 16 Feb 2018
FDA head vows to tackle high drug prices and drug makers ‘gaming the system’
15 February 2018 - FDA Commissioner Scott Gottlieb said he will do everything “within my lane” to combat high drug ...